Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Piezo1 in respiratory diseases: mechanotransduction, cell-specific functions, and translational implications.

Created on 16 Jul 2026

Authors

Min Tao, Yiqi Xu, Liyao Bai, Gang Wang, Wenhui Liang, Qianqian Chen, Chu Qin, Haoda Yu

Published in

Frontiers in physiology. Volume 17. Pages 1885524. Epub Jul 01, 2026.

Abstract

Piezo1 is a mechanically activated cation channel that converts membrane tension, shear stress, matrix stiffness, and tissue deformation into calcium-dependent signaling. In the respiratory system, Piezo1 has emerged as a key regulator of epithelial injury, endothelial barrier responses, pulmonary vascular remodeling, fibroblast activation, and immune cell function. This review synthesizes evidence linking Piezo1 to pulmonary fibrosis, pulmonary hypertension, asthma, acute respiratory distress syndrome, respiratory infection, and chronic obstructive pulmonary disease, while distinguishing direct Piezo1 evidence from broader mechanobiology support. Across these conditions, Piezo1 should not be interpreted as uniformly injurious or protective. Its net effect depends on the sensing cell type, force profile, disease phase, and downstream program engaged. We therefore propose a translational framework in which Piezo1-targeted strategies require temporal, regional, and lineage-specific control rather than systemic nonselective activation or inhibition.

PMID:
42460298
Bibliographic data and abstract were imported from PubMed on 16 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 11
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement